Anúncio
Anúncio

PRVA

PRVA logo

Privia Health Group, Inc. Common Stock

24.37
USD
Patrocinado
-0.05
-0.21%
07 de jan., 13:05 UTC -5
Abrir

Relatórios de Lucros PRVA

Rácio de surpresa positiva

PRVA separação 9 de 19 últimas estimativas.

47%

Próximo Relatório

Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$838.94M
/
$0.03
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-10.79%
/
-40.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+5.86%
/
--

Privia Health Group, Inc. Common Stock earnings per share and revenue

On 06 de nov. de 2025, PRVA reported earnings of 0.05 USD per share (EPS) for Q3 25, missing the estimate of 0.05 USD, resulting in a -8.93% surprise. Revenue reached 940.40 milhão, compared to an expected 797.58 milhão, with a 17.91% difference. The market reacted with a -4.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 21 analistas forecast an EPS of 0.03 USD, with revenue projected to reach 838.94 milhão USD, implying an diminuir of -40.00% EPS, and diminuir of -10.79% in Revenue from the last quarter.
FAQ
For Q3 2025, Privia Health Group, Inc. Common Stock reported EPS of $0.05, missing estimates by -8.93%, and revenue of $940.40M, 17.91% above expectations.
The stock price moved down -4.16%, changed from $25.02 before the earnings release to $23.98 the day after.
The next earning report is scheduled for 25 de fev. de 2026.
Based on 21 analistas, Privia Health Group, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $838.94M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio